Late-occurring toxicity induced by an immune checkpoint blockade in adjuvant treatment of a stage III melanoma patient

被引：24
|
作者：
Mandala, Mario [1 ]
Merelli, Barbara [1 ]
Indriolo, Amedeo [2 ]
Tondini, Carlo [1 ]
机构：
[1] Papa Giovanni XXIII Hosp, Dept Hematol & Oncol, Med Oncol Unit, Bergamo, Italy
[2] Papa Giovanni XXIII Hosp, Gastroenterol Unit, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 95卷
关键词：
ANTI-PD-1; THERAPY; IPILIMUMAB;
D O I：
10.1016/j.ejca.2018.02.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：130 / 132
页数：3
相关论文
共 50 条
  • [21] Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade Treatment
    Loo, Kimberly
    Kalvin, Hannah L.
    Panageas, Katherine S.
    Park, Vivian
    Postow, Michael A.
    ONCOLOGIST, 2022, 27 (09): : E755 - E758
  • [22] Response to Treatment for metastatic malignant Melanoma under double Immune Checkpoint Blockade
    Steimke, L.
    Rodig, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 15 - 15
  • [23] Caloric restriction mimetics as adjuvant to immune checkpoint inhibitors for treatment of melanoma.
    Morehead, Lauren C.
    Koss, Brian S.
    Wallis, Katherine F.
    Tackett, Alan J.
    Miousse, Isabelle Racine
    CANCER RESEARCH, 2021, 81 (13)
  • [24] T cell immune landscape in melanoma patients before and post immune checkpoint blockade treatment
    Luo, Ying
    Yao, Chen
    Wu, Tuoqi
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [25] T cell immune landscape in melanoma patients before and post immune checkpoint blockade treatment
    Luo, Ying
    Yao, Chen
    Wu, Tuoqi
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [26] Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
    Thilo Gambichler
    Stefanie Strutzmann
    Andrea Tannapfel
    Laura Susok
    BMC Cancer, 17
  • [27] Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
    Gambichler, Thilo
    Strutzmann, Stefanie
    Tannapfel, Andrea
    Susok, Laura
    BMC CANCER, 2017, 17
  • [28] Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
    Koch, Elias A. T.
    Petzold, Anne
    Wessely, Anja
    Dippel, Edgar
    Gesierich, Anja
    Gutzmer, Ralf
    Hassel, Jessica C.
    Haferkamp, Sebastian
    Kaehler, Katharina C.
    Knorr, Harald
    Kreuzberg, Nicole
    Leiter, Ulrike
    Loquai, Carmen
    Meier, Friedegund
    Meissner, Markus
    Mohr, Peter
    Pfoehler, Claudia
    Rahimi, Farnaz
    Schadendorf, Dirk
    Schell, Beatrice
    Schlaak, Max
    Terheyden, Patrick
    Thoms, Kai-Martin
    Schuler-Thurner, Beatrice
    Ugurel, Selma
    Ulrich, Jens
    Utikal, Jochen
    Weichenthal, Michael
    Ziller, Fabian
    Berking, Carola
    Heppt, Markus V.
    German Dermatologic Cooperat Oncol Grp
    CANCERS, 2022, 14 (03)
  • [29] Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant Approaches
    Tarhini, Ahmad A.
    Castellano, Ella
    Eljilany, Islam
    CANCER JOURNAL, 2024, 30 (02): : 54 - 70
  • [30] New paradigm for stage III melanoma: from surgery to adjuvant treatment
    Ascierto, Paolo Antonio
    Borgognoni, Lorenzo
    Botti, Gerardo
    Guida, Michele
    Marchetti, Paolo
    Mocellin, Simone
    Muto, Paolo
    Palmieri, Giuseppe
    Patuzzo, Roberto
    Quaglino, Pietro
    Stanganelli, Ignazio
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
12345